Sales Growth YoY (Last 12 Months): cgen.com (CGEN)

Public company logo of cgen.com (CGEN)

Compugen Ltd. is a recognized expert in identifying targets for cancer immunotherapy. An AI platform ensures high development efficiency, while revenue is based on strategic licensing agreements. The year-over-year sales trajectory over the trailing four quarters demonstrates revenue dynamics, where 995.50 expresses the latest metric level, allowing for an assessment of the business expansion rate.

Compugen Limited (CGEN) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/15/2026

Compugen Ltd. (CGEN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Compugen Ltd.|CGEN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Compugen Ltd|CGEN - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share Compugen|CGEN - Company Net Assets|Market Value to Equity Ratio cgen.com|CGEN - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital Compugen Ltd.|CGEN - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Compugen Limited|CGEN - Company Aggregate Debts|Debts to Book Value Compugen Ltd|CGEN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Compugen|Quick Ratio cgen.com
- earnings and market multiples details:
CGEN - Company Net Income|Forward Earnings Compugen Ltd.|CGEN - Price to Earnings Ratio|Projected Price to Earnings Ratio Compugen Limited|CGEN - PEG Multiple|Enterprise Value to EBITDA Ratio Compugen Ltd|CGEN - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Compugen|CGEN - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months cgen.com|CGEN - Earnings per share growth in current year|Net earnings per share change forecast for next year Compugen Ltd.
- sales and revenue indicators:
CGEN - Company Sales|Projected Sales Volume Compugen Limited|CGEN - P/S Multiple|Projected Price to Revenue Compugen Ltd.|CGEN - Sales Growth YoY (TTM)
Summary company analytics:Compugen Ltd.
Product sample of Compugen Limited

For a fundamental valuation of Compugen Ltd. (CGEN), it is critical to track revenue dynamics, which currently stand at 995.50. By analyzing the TTM sales growth rate, an investor can discern the business expansion pace over a rolling year, which, for a biotech sector company with an AI model, reflects the monetization efficiency of licensing agreements with pharma behemoths and the resilience of demand for innovative developments.

Competitors of Compugen Ltd. (CGEN)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)